Literature DB >> 10664993

Scintigraphic features of chronic sialadenitis and Sjögren's syndrome: a comparison.

G A Hermann1, F B Vivino, J E Goin.   

Abstract

An abnormal salivary scintigram is an accepted objective criterion in the diagnosis of primary and secondary Sjögren's syndrome, an immune-mediated disorder characterized by xerostomia and kerato-conjunctivitis sicca. However, chronic sialadenitis constitutes a major differential diagnostic consideration in the xerostomic population. We investigated 39 cases of biopsy-confirmed chronic sialadenitis and 152 individuals with first- or second-degree Sjögren's syndrome, according to international classification criteria. We analysed scintigraphic defects in terms of glands per patient, distribution patterns, kinetics and severity. Relative to Sjögren's syndrome, chronic sialadenitis showed significantly fewer defective glands per patient, less frequent dual parotid-submandibular defects, fewer combined deficits of uptake and discharge, and milder uptake failure. No statistically significant differences were found in the frequency of single gland abnormality, predilection for submandibular involvement, and respective proportions of uptake-only and discharge-only defects. Unevaluable discharge due to low uptake, although comprising only 34% of test-positive cases, appeared to be a highly specific but insensitive scintigraphic marker for Sjögren's syndrome. In non-irradiated xerostomic populations, scintigraphy provides specific, albeit limited, diagnostic information. The procedure's ability to distinguish uptake failure from secretory failure may be a useful asset in guiding clinical management strategies and estimating outcomes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10664993     DOI: 10.1097/00006231-199912000-00004

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

1.  [Sensory neuronopathy of Sjögren's syndrome. A diagnostic challenge].

Authors:  D Czell; R Baldinger; W Jochum; M Weber
Journal:  Nervenarzt       Date:  2012-02       Impact factor: 1.214

2.  [Sjögren's syndrome].

Authors:  T Witte
Journal:  Z Rheumatol       Date:  2014-02       Impact factor: 1.372

Review 3.  [Pathogenesis and diagnosis of Sjögren's syndrome].

Authors:  T Witte
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

Review 4.  Sjögren's syndrome: diagnosis and therapeutic challenges in the elderly.

Authors:  Kristine P Ng; David A Isenberg
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

5.  Quantitative Single-Photon Emission Computed Tomography/Computed Tomography for Evaluation of Salivary Gland Dysfunction in Sjögren's Syndrome Patients.

Authors:  Jihyun Kim; Hyunjong Lee; Hwanhee Lee; Ji-In Bang; Yeon-Koo Kang; Sungwoo Bae; Yoo Sung Song; Won Woo Lee
Journal:  Nucl Med Mol Imaging       Date:  2018-09-19

6.  The role of RORα in salivary gland lesions in patients with primary Sjögren's syndrome.

Authors:  Xiuhong Weng; Yi Liu; Shun Cui; Bo Cheng
Journal:  Arthritis Res Ther       Date:  2018-09-06       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.